ANN ARBOR – Marty Makary, head of the U.S. Food and Drug Administration (FDA) reported the agency will not interfere with a new federal policy providing Medicare beneficiaries coverage for hemp-derived CBD products. Makary said while the agency preserves its authority to regulate products containing hemp or hemp-derived compounds under the Food, Drug and Cosmetic (FD&C) Act, it will loosen its “enforcement posture” for certain CBD products eligi…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.